← Back to Search

Device Validation Using Blood Samples for Thrombotic Thrombocytopenic Purpura

N/A
Recruiting
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial is for a new device that needs to be validated with known samples. 3 ml of blood is needed from people diagnosed with hTTP. You will be compensated for your time and resources.

Who is the study for?
This trial is for individuals with hereditary thrombotic thrombocytopenic purpura (hTTP) who have an ADAMTS13 activity level below 1%. Participants will provide a small blood sample and receive $500 for their time.Check my eligibility
What is being tested?
The study involves a single blood draw to help validate a new diagnostic device. The company behind this has other devices on the market, and needs real patient samples to ensure the new instrument works correctly.See study design
What are the potential side effects?
Since the intervention only includes drawing blood, side effects are minimal but may include slight pain or bruising at the needle site, dizziness, or fainting.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Placebo Group
Group I: ParticipantsPlacebo Group1 Intervention
Anyone with Hereditary TTP

Find a Location

Who is running the clinical trial?

Media Library

Blood Draw Clinical Trial Eligibility Overview. Trial Name: IL — N/A
Thrombotic Thrombocytopenic Purpura Research Study Groups: Participants
Thrombotic Thrombocytopenic Purpura Clinical Trial 2023: Blood Draw Highlights & Side Effects. Trial Name: IL — N/A
Blood Draw 2023 Treatment Timeline for Medical Study. Trial Name: IL — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
California
Texas
Other
How old are they?
< 18
65+
18 - 65
What site did they apply to?
Any Pharmacy In Your City
Machaon Diagnostics
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria

How responsive is this trial?

Typically responds via
Phone Call
Recent research and studies
clinicaltrials.govStudy
Device validation study using blood from patients with Hereditary thrombotic thrombocytopenic purpura (TTP)
2022. "Device validation study using blood from patients with Hereditary thrombotic thrombocytopenic purpura (TTP)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/IL.
All > Hereditary Angioedema > Ic
~124 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top